Bioventus  logo
Bioventus BVS
$ 10.11 2.43%

Annual report 2025
added 03-05-2026

report update icon

Bioventus Operating Income 2011-2026 | BVS

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula
Operating profit = Revenue – Operating expenses
Features of the metric
  • Evaluates business efficiency
    Shows how well the company controls its production and administrative costs.
  • Independent of financial structure
    Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
  • Main source for growth
    High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Bioventus

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
54 M -15.2 M -81.7 M -167 M 12.1 M 21.2 M 31.2 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
54 M -167 M -20.8 M

Quarterly Operating Income Bioventus

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
11.3 M 18.4 M 4.87 M 3.65 M -31.5 M 4.93 M 2.42 M 6.75 M -92.1 M - -127 M -3.31 M -21.4 M - -1.05 M -5.74 M 22 M - 6.93 M -4.59 M 13 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
22 M -127 M -10.7 M

Operating Income of other stocks in the Diagnostics research industry

Issuer Operating Income Price % 24h Market Cap Country
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
-797 M $ 17.1 0.56 % $ 181 M chinaChina
CareDx, Inc CareDx, Inc
CDNA
-30.8 M $ 21.5 3.32 % $ 1.15 B usaUSA
Centogene N.V. Centogene N.V.
CNTG
-46 M - -6.23 % $ 30.6 M germanyGermany
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-14 M - -61.36 % $ 2.46 M usaUSA
Agilent Technologies Agilent Technologies
A
1.35 B $ 114.52 -0.86 % $ 34.8 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
-50.2 M $ 1.55 - $ 2.06 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
8.67 M $ 24.81 1.31 % $ 689 M usaUSA
Akumin Akumin
AKU
-28.1 M - -17.87 % $ 25.9 M canadaCanada
Biocept Biocept
BIOC
-32 M - -13.05 % $ 7.29 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
-7.91 M - -6.19 % $ 10.5 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
-73.9 M $ 14.13 -6.98 % $ 427 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
1.1 B $ 112.85 -4.63 % $ 9.31 B irlandaIrlanda
Chembio Diagnostics Chembio Diagnostics
CEMI
-23.6 M - 0.22 % $ 16.8 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
-25.9 M - - $ 9.42 M israelIsrael
Heska Corporation Heska Corporation
HSKA
-20.3 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
-20.8 M - -20.0 % $ 1.06 M usaUSA
Illumina Illumina
ILMN
-833 M $ 135.78 7.13 % $ 21.6 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
311 M $ 85.5 1.04 % $ 5.77 B usaUSA
DermTech DermTech
DMTK
-104 M - -11.32 % $ 2.94 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
609 M - - $ 399 M chinaChina
Genetron Holdings Limited Genetron Holdings Limited
GTH
-518 M - 0.12 % $ 80.1 M chinaChina
Myriad Genetics Myriad Genetics
MYGN
-387 M $ 4.8 1.05 % $ 444 M usaUSA
NeoGenomics NeoGenomics
NEO
-116 M $ 9.44 1.94 % $ 1.21 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
535 M $ 417.54 -0.27 % $ 12 B usaUSA
National Research Corporation National Research Corporation
NRC
22.6 M $ 17.41 5.77 % $ 390 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
25.2 M $ 165.78 -0.71 % $ 8.22 B usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
553 M $ 26.16 -0.87 % $ 20 B niderlandNiderland
Enzo Biochem Enzo Biochem
ENZ
-12.4 M - -8.98 % $ 14.8 K usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
-206 M - - $ 19.8 B usaUSA
Guardant Health Guardant Health
GH
-437 M $ 87.6 0.6 % $ 11 B usaUSA
Personalis Personalis
PSNL
-68.3 M $ 5.78 4.71 % $ 342 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
-11.9 M - -34.28 % $ 263 K israelIsrael
Interpace Biosciences Interpace Biosciences
IDXG
4.08 M $ 2.12 7.07 % $ 9.38 M usaUSA
Senseonics Holdings Senseonics Holdings
SENS
-68.3 M $ 5.1 -22.84 % $ 213 M usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
9.41 M $ 52.87 0.09 % $ 2.69 B usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
7.75 B $ 469.21 -2.04 % $ 177 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
466 M - - $ 10.6 B niderlandNiderland
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
-136 M $ 60.4 3.34 % $ 3.61 B usaUSA
Biomerica Biomerica
BMRA
-5.14 M $ 2.19 0.46 % $ 5.03 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
1.38 B $ 255.84 -0.37 % $ 21.3 B usaUSA
Celcuity Celcuity
CELC
-172 M $ 125.65 3.54 % $ 5.88 B usaUSA
Natera Natera
NTRA
-541 M $ 207.28 0.54 % $ 20.4 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
-1.06 B $ 9.53 1.38 % $ 2.07 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
-94.9 M - - $ 21.2 M usaUSA
Waters Corporation Waters Corporation
WAT
271 M $ 307.12 -0.68 % $ 18.3 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
1.56 B $ 192.67 -0.79 % $ 21.4 B usaUSA